You are here: Home » Products » API » Enrofloxacin Hydrochlorid
Product Search

Product Details

Share to:

Enrofloxacin Hydrochlorid

Quantity:

Enrofloxacin Hydrochlorid, Enrofloxacin HCL

CAS number: 93106-60-6

Molecular formula: C19H22FN3O3

Molecular weight: 359.39

Packing: 25kg/drum

Shelf Life: 3 years

Specification:

Tests

Acceptance Criteria

Results

Description

Slightly yellow  or pale orange yellow crystalline powder, odorless,slightly bitter;becoming orange-red on exposure to light.

 Slightly yellow crystalline powder

Freely soluble in chloroform and in sodium hydroxide TS , slightly soluble in methanol , very slightly soluble in water , sparingly soluble in

dimethylformamide.

 

/

Melting range

221~226℃

223.0-223.5℃

Identification

 HPLC:Similar in retention time to the principal peak of the reference.

 

Conforms

IR:Conforms to the reference spectrum.

Clarity of solution

 Clear (1g/20ml in 0.5mol/Lin NaOH Solution)

Conforms

Color of solution

Not more intensely coloured than GY4 or Y4 (1g/20ml in 0.5mol/Lin NaOH Solution)

Conforms

Fluoroquinolonic acid (TLC)

≤0.2%

Conforms

Related substance(HPLC)

(1) Ciprofloxacin

≤0.5%

0.02%

(2) Any other single impurity

≤0.3%

0.13%

(3) Total impurities

≤0.7%

0.13%

Loss on drying

≤0.5%(105℃)

0.09%

Residue on ignition

≤0.2%

<0.01%

Heavy metals

≤20ppm

<20ppm

Assay

C19H22FN3O3  99.0~101.0% (Dried substance)

99.9%

Conclusion: conforms to Chinese Veterinary Pharmacopoeia 2015 (Ⅰ) specification for enrofloxacin base.

 

Description:Enrofloxacin is a broad spectrum bactericidal drugs, have special effects on mycoplasma. White on escherichia coli, klebsiella bacillus coli, pseudomonas aeruginosa, salmonella, deformation, haemophilus, kill, pasteurella, streptococcus hemolytic pap coli, s. aureus bacteria, such as have antiseptic effect.

 

Function:

Dogs and Cats

The product is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

 Cattle

Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

 Pigs

Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

 

 


Home

Add: Dinghao Square, No. 44, Gong Ye Nan Road, High-tech Zone, Jinan, Shandong Province, China    QQ: 121737357 /  2133109232   Skype: simonjh127  / bill.am@outlook.com 
Tel: +86-13145317722  +86-18254138679    Email: simon@anderchem.com / bill@anderchem.com
Copyright © 2019 Jinan Andechem Company Limited.  Sitemap. Support By Sdzhidian